We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04103450
Recruitment Status : Completed
First Posted : September 25, 2019
Last Update Posted : August 24, 2022
Information provided by (Responsible Party):
Urovant Sciences GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 29, 2022
Actual Study Completion Date : July 29, 2022
Certification/Extension First Submitted : August 23, 2022